AACR 2023: Researchers report results in rare gynaecologic cancers from DART immunotherapy trial
Results from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus…
Browsing: AACR
AACR 2023: Mutations in three key genes associated with poor outcomes in lung cancer patients treated with KRAS G12C inhibitors
A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that…
AACR 2023: Novel allogeneic CAR T cell therapy delivers promising early results in metastatic clear cell renal cell carcinoma
The CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouraging response rates and…
AACR 2023: Scientists create powerful, most-accurate tools to research deadliest blood cancer, study says
Tisch Cancer Center scientists developed unique models of the deadliest blood cancer, acute myeloid leukaemia…
AACR 2023: Treatment with immunotherapy alone produces ‘exceptional’ response rates in some melanoma patients
Data from a national clinical trial shows that a striking 89% of patients with desmoplastic…
AACR 2023: Enzyme shows promise as target to treat HPV negative head and neck cancer
Vinita Takiar’s lab in UC’s Department of Radiation Oncology studies how to improve radiation therapy…
AACR 2022: Using AI to predict side effects from new anticancer drug combinations
Preliminary data from an artificial intelligence model could potentially predict side effects resulting from new…
AACR 2022: Two drugs targeting DNA damage response show promise in early-stage cancer trials
Results from early-stage clinical trials show two drugs that target the DNA damage response (DDR)…
AACR 2022: Team of scientists and clinicians wins global award for transforming breast cancer treatment
A group of UK clinical and non-clinical scientists working together across different areas of cancer…
AACR 2022: Paediatric cancer patients in lower-and middle-income countries faced significantly higher mortality risk during the COVID-19 pandemic
During the first nine months of the COVID-19 pandemic, paediatric cancer patients from lower-and middle-income…